Akso Health Group ADR (AHG) financial statements
Akso Health Group ADR reported revenue of $14M in fiscal 2026, down 5.5% a year over 9 years.
Net income was -$19M and the operating margin -149.7%, against 43.3% in 2017.
Free cash flow was -$13M.
The diluted share count rose 5022% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Akso Health Group ADR's 10-K filings with the SEC.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23M | $107M | $4M | $7M | $2M | $6M | $13M | $2M | $15M | $14M |
| Cost of revenue | $5M | $8M | $7M | $1M | $544,572 | $5M | $12M | $2M | $15M | $14M |
| Gross profit | $23M | $107M | -$4M | $7M | $2M | $605,134 | $1M | $122,132 | -$281,526 | -$11,315 |
| Research and development | $2M | $3M | $0 | $117,942 | $441,405 | $421,186 | — | — | — | — |
| Selling, general and admin | $8M | $21M | $4M | $22M | $3M | $3M | $16M | $9M | $4M | $4M |
| Operating income | $10M | $76M | -$7M | -$48M | -$4M | -$3M | -$14M | -$9M | -$166M | -$21M |
| Interest expense | — | — | — | — | $2M | $804,138 | — | — | — | — |
| Pre-tax income | $10M | $77M | -$7M | -$47M | -$4M | -$4M | -$13M | -$9M | -$166M | -$21M |
| Income tax | $2M | $11M | $807,710 | $489,955 | $482,976 | $92,816 | $17,549 | $24,988 | -$31M | -$2M |
| Net income | $9M | $65M | $6M | -$71M | -$35M | -$17M | -$1M | -$9M | -$135M | -$19M |
| EPS (diluted) | $0.20 | $1.37 | $0.10 | -$1.46 | -$0.71 | -$0.28 | -$0.02 | $0.07 | $0.16 | $0.01 |
| Diluted shares | 42M | 48M | 53M | 49M | 49M | 60M | 69M | 142M | 855M | 2.17B |
| Gross margin | 100.0% | 100.0% | -100.2% | 100.0% | 100.0% | 9.6% | 9.6% | 5.1% | -1.9% | -0.1% |
| Operating margin | 43.3% | 70.7% | -194.6% | -695.7% | -241.7% | -51.7% | -108.2% | -357.8% | -1125.4% | -149.7% |
| Net margin | 37.4% | 61.1% | 149.7% | -1029.7% | -1984.5% | -267.0% | -10.3% | -391.8% | -913.4% | -135.0% |
Balance sheet
Fiscal years, from Akso Health Group ADR's 10-K filings with the SEC.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $19M | $133M | $57M | $7M | $15M | $18M | $8M | $85M | $176M | $170,572 |
| Receivables | — | $0 | $140,639 | — | — | — | $8M | — | $954,200 | $1M |
| Inventory | — | — | — | — | — | $8M | $2M | $191,201 | $190,242 | $200,135 |
| Total current assets | — | $163M | $98M | $52M | $30M | $63M | $20M | $142M | $196M | $190M |
| Property, plant and equipment | $427,938 | $767,087 | $1M | $92,832 | $66,887 | $55,433 | — | — | $16,148 | $12,015 |
| Goodwill | — | — | — | — | — | — | — | — | $11M | — |
| Total assets | $28M | $164M | $173M | $80M | $51M | $63M | $20M | $142M | $215M | $190M |
| Total current liabilities | — | $24M | $27M | $12M | $14M | $51M | $12M | $4M | $14M | $9M |
| Total liabilities | $5M | $24M | $47M | $32M | $14M | $51M | $12M | $4M | $16M | $9M |
| Shareholders' equity | $24M | $140M | $127M | $48M | $17M | $12M | $9M | $138M | $199M | $181M |
| Net debt | -$19M | -$133M | -$57M | -$7M | -$15M | -$18M | -$8M | -$85M | -$176M | -$170,572 |
Cash flow
Fiscal years, from Akso Health Group ADR's 10-K filings with the SEC.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $8M | $88M | -$2M | -$58M | $10M | -$9M | -$3M | $1M | $1M | -$13M |
| Capital spending | $287,765 | $456,030 | $7,590 | $200,360 | — | $4,861 | — | — | $154,460 | $1,638 |
| Free cash flow | $8M | $87M | -$2M | -$58M | — | -$9M | — | — | $1M | -$13M |
| Stock-based compensation | $0 | $2M | $7M | $347,466 | $55,468 | $391,625 | — | — | — | — |
| Dividends paid | — | — | $20M | — | — | — | — | — | — | — |
| Share buybacks (net) | — | — | -$1M | -$3M | — | — | — | — | — | — |
| Free cash flow margin | 34.5% | 81.4% | -47.1% | -845.7% | — | -136.8% | — | — | 6.9% | -92.5% |
| Dividends per share | — | — | $0.37 | — | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AHG.
Open AHG in InvestinglyQuestions
What was Akso Health Group ADR's revenue in 2026?
$14M in fiscal 2026, from its 10-K filing.
How much free cash flow does Akso Health Group ADR generate?
-$13M in fiscal 2026 (operating cash flow minus capital spending).
From Akso Health Group ADR's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.